The Trillion-Dollar Weight: How Federal Healthcare Subsidies and Tax Preferences Drive America’s Fiscal Crisis

Main Facts The United States federal government faces an unprecedented fiscal trajectory, defined by historical deficits and a debt-to-GDP ratio on track to shatter previous records. According to projections from the Congressional Budget Office (CBO), deficits as a share of Gross Domestic Product (GDP) will climb from 5.8 percent in 2026 to 6.7 percent in…

Read Full News

The Trillion-Dollar Weight: How Healthcare Subsidies and Tax Preferences Are Driving America’s Fiscal Crisis

Main Facts The United States federal government faces an unprecedented fiscal trajectory, driven largely by decades of escalating healthcare spending and extensive tax preferences. According to Congressional Budget Office (CBO) projections, federal budget deficits as a share of Gross Domestic Product (GDP) are set to rise from 5.8 percent in 2026 to 6.7 percent in…

Read Full News

Navigating the Financial and Emotional Weight of an Inheritance: A Strategic Guide

An inheritance is often described as a double-edged sword: while it represents a significant shift in one’s financial trajectory, it almost invariably arrives accompanied by the profound emotional weight of grief. Managing a windfall of this nature requires more than just financial acumen; it demands a measured approach that balances the logistical complexities of asset…

Read Full News

Medicare’s "Bridge" Program Offers Temporary Lifeline for GLP-1 Weight Loss Drugs, But Questions Linger

For years, Medicare beneficiaries seeking the groundbreaking GLP-1 medications for weight loss faced a definitive "no." However, a new initiative, dubbed the "Medicare GLP-1 Bridge short-term demonstration," is poised to change that narrative, albeit with significant caveats. Starting July 1, 2026, eligible individuals will gain access to certain GLP-1 drugs, like Wegovy (which shares the…

Read Full News